{
  "completed": true,
  "status": "documented_historical_discovery_and_reconciliation",
  "provider": "Consensus",
  "provider_mode": "Historical browser/connector use as recorded in the source artifacts",
  "local_audit_date": "2026-10-09",
  "primary_comparison_count": null,
  "reported_usage": [
    {
      "path": "D:\\HypothesisCritic\\deliverables\\hsef_v53_popularity_ranks_36_40_2026-10-08\\oncogene-addiction\\consensus\\usage.json",
      "metrics": {
        "deep_queries": 0,
        "api_calls": 0,
        "browser_pro_queries": 2,
        "targeted_studies_requested": 8,
        "original_passage_comparisons": 1
      }
    }
  ],
  "grade_changed": false,
  "score_before": {
    "hsef_level": "Η",
    "hsef_descriptor": "Strong convergent causal evidence, intervention-sensitive",
    "confidence": "Moderate",
    "confidence_rationale": "66 primary reports with 9 selected partial-body examinations; density, heterogeneous controls and incomplete access set the confidence, not correctness.",
    "rests_on_non_peer_reviewed_work": false,
    "rationale": "The preregistered scope-matched rule reports SC1 at Η: endogenous conditional-driver and common-conduit interventions, genetic withdrawal, mechanistic resistance/rescue and baseline molecularly defined clinical trials converge on tumor-maintenance dependence across named pairs. Significant primary nonresponse, host/apoptosis dependence and persistence prevent Θ or Ω. SC2 pan-cancer one-driver generalization and SC3 residual-cell eradication remain Γ as broader mechanistic claims without matching general causal validation."
  },
  "score_after": {
    "hsef_level": "Η",
    "hsef_descriptor": "Strong convergent causal evidence, intervention-sensitive",
    "confidence": "Moderate",
    "confidence_rationale": "66 primary reports with 9 selected partial-body examinations; density, heterogeneous controls and incomplete access set the confidence, not correctness.",
    "rests_on_non_peer_reviewed_work": false,
    "rationale": "The preregistered scope-matched rule reports SC1 at Η: endogenous conditional-driver and common-conduit interventions, genetic withdrawal, mechanistic resistance/rescue and baseline molecularly defined clinical trials converge on tumor-maintenance dependence across named pairs. Significant primary nonresponse, host/apoptosis dependence and persistence prevent Θ or Ω. SC2 pan-cancer one-driver generalization and SC3 residual-cell eradication remain Γ as broader mechanistic claims without matching general causal validation."
  },
  "independent_blinded_audit": false,
  "raw_receipts": [
    {
      "path": "deliverables\\hsef_v53_popularity_ranks_36_40_2026-10-08\\oncogene-addiction\\consensus-anchors-search-log.json",
      "sha256": "64ce1aa64272d7998b58f19b64666b0d975ec34289fa581177281317159af959"
    },
    {
      "path": "deliverables\\hsef_v53_popularity_ranks_36_40_2026-10-08\\oncogene-addiction\\consensus-anchors.json",
      "sha256": "b071f0bcc115e90ce219ed41e0d6fcaf433addcdade19947601b74709f803fcc"
    },
    {
      "path": "deliverables\\hsef_v53_popularity_ranks_36_40_2026-10-08\\oncogene-addiction\\consensus\\broad-ax.txt",
      "sha256": "ecf1c27fd264b3682cbce92aa9c782b64f9ab80f5ee5be3e2693a5f9e4387e3e"
    },
    {
      "path": "deliverables\\hsef_v53_popularity_ranks_36_40_2026-10-08\\oncogene-addiction\\consensus\\RECONCILIATION.md",
      "sha256": "525282c8473fdd140433542bfdc46ca31a6277c99267a78b7f791b684c11b9ac"
    },
    {
      "path": "deliverables\\hsef_v53_popularity_ranks_36_40_2026-10-08\\oncogene-addiction\\consensus\\targeted-ax.txt",
      "sha256": "f329a8b2fbd9fef059363a9542477cdf85b4b0fcf0abb074f4c109856707d0cf"
    }
  ],
  "limitations": "This verifies documented historical use and links the record to the final edition. It adds no primary-source, full-text, independence or verification credit. Original access remains limited to the source-specific record."
}